Exploratory Analysis of the Effects of Celecoxib on Cognitive Function in Vortioxetine-Treated Patients With Major Depressive Disorder in the PREDDICT Study
The Journal of Clinical Psychiatry · 2023
DOI: 10.4088/jcp.23m14829 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Psychiatry, 2023. Verfasst von Emma Sampson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Psychiatry, Adelaide Medical School, University of Adelaide, Australia. Hauptthemen laut MEDLINE: Major Depressive Disorder. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Objective
Major depressive disorder (MDD) remains difficult to treat, with many patients resistant to existing treatments or experiencing relapse. Cognitive dysfunction is associated with more severe clinical outcomes. Vortioxetine has shown efficacy in remediating depression-associated cognitive impairment. Anti-inflammatory augmentation of antidepressants is a new strategy in treating depression and has not previously been assessed for effects on cognition in depression.
Methods
Exploratory analyses were performed on secondary outcome cognitive data from the PREDDICT parallel-group, randomized, double-blind, placebo-controlled trial at the University of Adelaide (Australia).
Participants
(N = 119) with MDD (validated with Mini-International Neuropsychiatric Interview for DSM-IV) were treated with vortioxetine and celecoxib or vortioxetine and placebo for 6 weeks between December 2017 and April 2020. Measures included objective cognition composite scores (Choice Reaction Time, N-Back, Digit Symbol Substitution Test, Trail Making Task Part B), subjective cognition scores (Perceived Deficits Questionnaire), and global cognition composite scores (combined objective and subjective scores) derived from the THINC integrated tool (THINC-it). High-sensitivity C-reactive protein (hsCRP) measured at baseline and week 6 was tested for a predictive relationship with cognitive outcomes.
Results
Cognition composite scores demonstrated improvement by week 6 in both treatment groups. However, there was no significant interaction between change over time and treatment group. HsCRP did not have a significant relationship with any tested cognition measures.
Conclusions
Both treatment groups showed a reduction in depression-associated cognitive impairment. No superior clinical effect was reported for the add-on celecoxib group. HsCRP was modulated by neither vortioxetine nor add-on celecoxib. Trial Registration: ANZCTR identifier: ACTRN12617000527369.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Discipline of Psychiatry, Adelaide Medical School, University of Adelaide, Australia.
- Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka City, Japan (Hori).
- Department of Psychiatry, University of Münster, Münster, Germany (Schwarte, Hohoff, Baune).
- Department of Psychiatry, University of Münster, Münster, Germany.
- Northern Adelaide Mental Health Service, Salisbury, Australia.
- Hopwood Centre for Neurobiology, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia.
Zitieren
APA
Sampson, E., Mills, N. T., Hori, H., Schwarte, K., Hohoff, C., Schubert, O., Clark, S. R., Fourrier, C., & Baune, B. T. (2023). Exploratory Analysis of the Effects of Celecoxib on Cognitive Function in Vortioxetine-Treated Patients With Major Depressive Disorder in the PREDDICT Study. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.23m14829
Vancouver
Sampson E, Mills NT, Hori H, Schwarte K, Hohoff C, Schubert O, et al. Exploratory Analysis of the Effects of Celecoxib on Cognitive Function in Vortioxetine-Treated Patients With Major Depressive Disorder in the PREDDICT Study. The Journal of Clinical Psychiatry. 2023. doi:10.4088/jcp.23m14829
BibTeX
@article{Sampson2023,
author = {Sampson, Emma and Mills, Natalie T and Hori, Hikaru and Schwarte, Kathrin and Hohoff, Christa and Schubert, Oliver and Clark, Scott R and Fourrier, Célia and Baune, Bernhard T},
title = {Exploratory Analysis of the Effects of Celecoxib on Cognitive Function in Vortioxetine-Treated Patients With Major Depressive Disorder in the PREDDICT Study},
journal = {The Journal of Clinical Psychiatry},
year = {2023},
doi = {10.4088/jcp.23m14829}
}
EUVIMED